Premium
Release of LPL activity after intravenous injection of a low molecular weight heparin.
Author(s) -
Etienne J,
Millot F,
Pieron R,
Laruelle P
Publication year - 1983
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1983.tb02246.x
Subject(s) - lipoprotein lipase , heparin , low molecular weight heparin , lipase , anticoagulant , chemistry , hepatic lipase , pharmacology , in vitro , medicine , biochemistry , enzyme
A low molecular weight heparin (MW 4000‐6000), PK 10169 (Pharmuka), with much reduced anticoagulant in vitro capacity, retains the properties of the standard heparin in releasing lipoprotein lipase and hepatic lipase activity after being injected intravenously.